TickerFacts.

Company research / SHC

Sotera Health Co (SHC)

Build a valuation ↗↓ Download CSV

CIK 0001822479 · Nasdaq · Services-Misc Health & Allied Services, NEC

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Sotera Health Co reported revenue of $1.16B. Revenue grew 5.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.22B.

Key ratios (year ended 2025-12-31)

55.5%
Gross margin
6.7%
Net margin
12.9%
Return on year-end equity
5.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$1.22B$1.16B$1.10B$1.05B$1.00B$931.48M$818.16M$778.33M
Cost of Revenue$547.66M$518.08M$498.15M$472.13M$446.68M$412.81M$374.59M$382.90M
Gross Profit$668.51M$645.53M$602.29M$577.16M$557.00M$518.67M$443.57M$395.43M
Operating Incomen/an/a$297.63M$276.69M$248.35M$256.73M$206.02M$183.60M
Depreciation & Amortizationn/a$94.90M$84.30M$76.60M$64.30M$64.20M$63.30M$66.70M
EBITDAn/an/a$381.93M$353.29M$312.65M$320.93M$269.32M$250.30M
Net Income$163.48M$77.95M$44.40M$51.38M-$233.57M$116.88M-$38.62M-$20.85M
EPS (Diluted)n/a$0.27$0.16$0.18-$0.83$0.41-$0.16-$0.09
Total Assets$3.31B$3.26B$3.07B$3.13B$3.12B$2.79B$2.76Bn/a
Total Liabilities$2.64B$2.66B$2.67B$2.69B$2.77B$2.20B$2.31Bn/a
Long-Term Debt$2.14B$2.14B$2.22B$2.23B$1.94B$1.74B$1.82Bn/a
Shareholders' Equity$665.65M$606.03M$404.91M$443.73M$350.24M$586.10M$452.30Mn/a
Cash & Equivalents$356.72M$344.62M$277.24M$296.41M$395.21M$106.92M$102.45Mn/a
Operating Cash Flow$292.19M$287.19M$224.16M-$147.73M$277.96M$281.55M$120.58M$149.04M
Capital Expenditures$179.49M$138.02M$179.07M$214.97M$182.38M$102.16M$53.51M$57.26M
Free Cash Flow$112.70M$149.18M$45.09M-$362.71M$95.58M$179.38M$67.08M$91.78M
Share Repurchasesn/an/an/an/a$0$0$34.00M$0
Dividends Paidn/an/an/an/an/a$0$0$691.17M
Weighted Average Diluted Sharesn/a286.42M284.91M283.22M280.10M279.38M237.70M232.40M
EPS (Basic)n/a$0.27$0.16$0.18-$0.83$0.41-$0.16-$0.09

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView